News and Announcements
Proteomics International Laboratories Signs Largest Analytics Contract to Date & Becomes the World’s Most Accredited Protein Testing Lab
- Published August 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Medical technology company Proteomics International Laboratories Ltd (ASX: PIQ) is pleased to provide the following update on its business activities for the three-month period to 30 June 2017.
KEY TAKEAWAYS:
- Validation study confirms PromarkerD can predict diabetic kidney disease better than any current measure.
- Results of the validation study were presented to world’s largest gathering of diabetes experts at the American Diabetes Association’s 77th Annual Scientific Sessions.
- New potential income stream through analytical services for clinical trials.
- Proteomics International became the world’s most accredited protein testing laboratory, and launched pharmacokinetic and companion diagnostic testing for clinical trials.
- Largest analytics contract to date (worth A$200,000) was signed, and year on year income growth is 28%. PIQ is aiming for its operations to be cashflow break even by the end of the 2017/18 financial year.